Director’s Messages

In this message for National Eating Disorder Awareness Week, Dr. Gordon highlights NIMH-funded research aimed at reducing the impact of eating disorders.

In this jointly written Director’s Message, leadership from across NIH encourages the neuroscience community to take advantage of the new NIH-wide FIRST Program, which aims to enhance cultures of inclusive excellence through institutional support for recruitment of diverse “cohorts” of early-stage research faculty. 

In Dr. Gordon’s latest Director's Message, he expresses support for the critical work of NIMH’s Dr. Elisabeth Murray and others who are advancing brain science through basic research.

In this Director’s message, Dr. Gordon shares a personal perspective on the importance of remembering the individual lives that have been lost to COVID-19.

In this message, Dr. Gordon highlights a new public-private partnership that aims to develop novel treatment approaches that will make a meaningful difference in the lives of individuals at risk of schizophrenia.

In this message for National Suicide Prevention Month, Dr. Gordon describes NIMH’s efforts to address the rising rates of suicide in the U.S. among Black youth.

In a previous message, Dr. Gordon discussed how the Research Domain Criteria (RDoC) framework has changed the conversation in mental health research since its initiation in 2010. In this message, he looks forward to the next ten years of RDoC.

In this message, Dr. Gordon joins with 10 other NIH Institute Directors to highlight the importance and necessity of COVID-19 testing and the ways NIH is helping establish programs that will ensure access to and acceptance of rapid and reliable testing for COVID-19.

In the first of two Director’s Messages to mark the 10-year anniversary of the creation of the Research Domain Criteria (RDoC) initiative, Dr. Gordon discusses the initial purpose of RDoC and the progress made over the last ten years.

In this message, Dr. Gordon joins with 10 other NIH Institute Directors to spotlight NIH’s Rapid Acceleration of Diagnostics (RADx) initiative — a national call for scientists and organizations to advance their innovative ideas for new COVID-19 testing approaches and strategies.